Skip to main content

Featured

Kremlin Strikes Optimistic Tone as Officials Praise Trump’s Approach

  Deputy Chairman of the Russian Security Council Dmitry Medvedev attends an interview with Reuters, TASS and WarGonzo in the Moscow region, Russia January 29, 2026. Dmitry Medvedev's Secretariat. Russian officials have adopted a noticeably warmer tone toward U.S. President Donald Trump, offering public praise that signals a potential shift in the diplomatic atmosphere between Washington and Moscow. Recent comments from senior Russian figures highlight what they describe as Trump’s decisiveness and willingness to pursue negotiated solutions to global conflicts. Dmitry Medvedev, deputy chairman of Russia’s Security Council, characterized Trump as an “effective leader” whose unconventional style reflects a pragmatic focus on results. He suggested that Trump’s stated interest in ending the war in Ukraine could open the door to renewed dialogue. President Vladimir Putin echoed this sentiment, calling Trump a resilient and courageous figure, particularly in light of recent threats to...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment